Systemic mastocytosis

Digestive Diseases

Volumn 17, Issue 5-6, 1999, Pages 299-307

  Karnam, Umaprasanna S ^b   Rogers, Arvey I ^a  

^a Division of Gastroenterology (D 49)   (United States)

^b NONE

Author keywords

Cromolyn; Histamine; Histamine antagonists; Mast cell; Mediators; PGD2; Steroids; Tryptase; Urticaria pigmentosa

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ALPHA INTERFERON; ASTEMIZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONTRAST MEDIUM; CROMOGLYCATE DISODIUM; CYTOKINE; DEXTRAN; DOXEPIN; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN E; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; STEROID; SUXAMETHONIUM; TERFENADINE; VENOM;

CELL ACTIVATION; CLINICAL FEATURE; GASTROINTESTINAL SYMPTOM; HUMAN; MAST CELL; MASTOCYTOSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PUVA; REVIEW;

EID: 0033506024     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016955     Document Type: Review

References (85)

1. Horan RF, Austen KF: Systemic mastocytosis: Retrospective review of a decade's clinical experience at the Brigham and Women's hospital. J Invest Dermatol 1991;96(suppl):5S-11S.
2. Nettleship E, Tay W: Rare forms of urticaria. Br Med J 1869;ii:323-324.
3. Ehrlich P: Beiträge zur Kenntniss der Anilinfarbungen und iher Verwendurg in der Mikroskopischen Technik. Arch Midros Anat 1877;13: 263-277.
4. Ehrlich P: Beiträge zur Kenntniss der granulirten Bindegewebszellen und der eosinophilen Leukocythen. Arch Anat Physiol 1879;3:166-169.
5. Unna PG: Beiträge zur Anatomie und pathogenese der urticaria simplex und pigmentosa. Mschr Prakt Dermat Studien 1887;3H:1.
6. Jeanselme E, Touraine A: Urticaire pigmentaire avec hypertrophie du foie et splénomégalie, hématologie, radiothérapie. Bull Soc Fr Derm Syph 1919;26:98-101.
7. Sézary A, Levy-Coblenz G, Chauvillon P: Dermatographisme et mastocytose. Bull Soc Fr Derm Syph 1936;43:357-359.
8. Ellis JM: Urticaria pigmentosa: A report of a case with autopsy. Arch Pathol 1949;48:426-435.
9. Krishenbaum AS, Kessler SW, Goff JP, Metcalfe DD: Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J Immunol 1991;146:1410-1415.
10. Longley BJ, Morganroth GS, Tyrell L, Ding TG, Anderson DM, Williams DE, Halaban R: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med 1993;328:1302-1307.
11. Funasaka Y, Boulton T, Cobb M: c-kit kinase induces a cascade of protein lyrosine phosphorylation in normal human melanocytes in response to mast cell growth factor and stimulates mitogen-activated protein kinase but is down-regulated in melanomas. Mol Biol Cell 1992;3:197-209.
12. Stevens RL, Usten KF: Recent advances in the cellular and molecular biology of mast cells. Immunol Today 1989;10:381-386.
13. Weber S, Kruger-Krasagakes S, Grabbe J: Mast cells. Int J Dermatol 1993;34:1-10.
14. Weidner N, Austen KF: Ultrastructural and immunohistochemical characterization of normal must cells at multiple body sites. Invest Dermatol 1991;96S:26S-31S.
15. Wasserman SI: Mast cell biology. J Allergy Clin Immunol 1990;86:590-593.
16. Galli SJ, Tsai M, Wershil BK: The c-kit receptor, stem cellfactor and mast cells. Am J Pathol 1993; 142:965-974.
17. Gordon JR, Burd PR, Galli SJ: Mast cells as a source of multifunctional cytokines. Immunol Today 1990;11:458-464.
18. Graham A, Thody AJ: Mast cell growth factor increases the survival of human melanocytes in culture. Br J Dermatol 1996;134:580.
19. Burd PR, Rogers HW, Gordon JR: Interleukin 3-dependent and independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989;170:245-257.
20. Galli SJ: New concepts about the mast cell. N Engl J Med 1993;328:257-265.
21. Williams DE, Eisenman J, Baird A, Rauch C, Ness KV, March CJ, Park LS, Martin U, Mochizuki DY, Boswell HS, Burgess GS, Cosman D, Lyman SD: Identification of a ligand for the c-kit proto-oncogene. Cell 1990;63:167-174.
22. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe D: Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematological disorder. Proc Natl Acad Sci USA 1995; 92:10560-10564.
23. Longley BJ, Tyrell L, Lu S-Z: Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in human mast cell neoplasm. Nat Gen 1996;12:312-314.
24. Miner PB Jr: The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis. J Invest Dermatol 1991; 96S:40S-44S.
25. Tharp MD: The spectrum of mastocytosis. Am J Med Sci 1985;289:119-132.
26. Sagher F, Even-Paz Z: Mastocytosis and the Mast Cell. Chicago, Yearbook Medical Publishers, 1967.
27. Golkar L, Bernhard JD: Mastocytosis. Lancet 1997;349:1379-1385.
28. Cherner JA, Jensen RT, Dubois A, O'Dorisio TM, Gardner JD, Metcalfe DD: Gastrointestinal dysfunction in systemic mastocytosis: A prospective study. Gastroenterology 1988;95: 657-667.
29. Belcon MC, Collins SM, Castell MF, Qizilbash A: Gastrointestinal hemorrhage in mastocytosis. CMA J 1980;122:311-314.
30. Cleavinger P, Alexander J: A case report of bacterial overgrowth causing diarrhea in systemic mastocytosis. Am J Gastroenterol 1990;150.
31. Weber S, Krasagakes SK, Grabbe J, Zuberbier T, Czarnetzki BM: Mast cells. Int J Dermatol 1995;34:1-11.
32. Lerno G, Slaats G, Coenen E, Herregods L, Rolly G: Anaesthetic management of systemic mastocytosis. Br J Anaesth 1990;65:254-257.
33. Debeuckelaeres A, Buydens B, Roosens P: Pancreatic calcifications and abdominal pain in a patient with systemic mastocytosis. Eur J Int Med 1989;1:65.
34. Bank S, Marks IN: Malabsorption in systemic mast cell disease. Gastroenterology 1963;45: 535-549.
35. Ammann RW, Vetter D, Deyhle P, Tschen H, Suscler H, Schmid M: Gastrointestinal involvement in systemic mastocytosis. Gut 1976;17: 107-112.
36. Yam LT, Chan CH, Li CY: Hepatic involvement in systemic mast cell disease. Am J Med 1986; 80:819-826.
37. Lennert K, Parwaresch MR: Mast cells and mast cell neoplasia: A review. Histopathology 1979;3:349-365.
38. Webb TA, Lin CY, Yam LT: Systemic mast cell disease: A clinical and hematopathologic study of 26 cases. Cancer 1982;49:927-938.
39. Capron JP, Lebrec D, Degott C, Chivrac D, Coevoet B, Delobel J: Portal hypertension in systemic mastocytosis. Gastroenterology 1978; 74:595-597.
40. Fishman RS, Fleming CR, Chen-Yang L: Systemic mastocytosis with review of gastrointestinal manifestations. Mayo Clin Proc 1979;54: 51-54.
41. Gonella JS, Lipsey AI: Mastocytosis manifested by hepatosplenomegaly: Report of a case. NEJM 1964;271:533-535.
42. Dantzig PI: Tetany, malabsorption and mastocytosis. Arch Intern Med 1975;135:1514-1518.
43. Ghandur-Mnaymneh L, Gould E: Systemic mastocytosis with portal hypertension. Arch Pathol Lab Med 1985;109:76-78.
44. Roberts LJ, Fields JP, Oates JA: Mastocytosis without urticaria pigmentosa: A frequently unrecognized cause of recurrent syncope. Trans Assoc Am Phys 1982;95:36-41.
45. Bredfeldt JE, O'Laughlin JC, Durham JB, Blessing LD: Malabsorption and gastric hyperacidity in systemic mastocytosis. Am J Gastroenterol 1980;74:133-137.
46. Scott BB, Hardy GJ, Losowsky MS: Involvement of the small intestine in systemic mast cell disease. Gut 1975;16:918-924.
47. Strobel S, Miller H, Ferguson A: Human intestinal mast cells: Evaluation of staining and fixing techniques. J Clin Pathol 1981;34:851-858.
48. Ferguson J, Thompson RPH, Greaves MW: Intestinal mucosal mast cells: Enumeration in urticaria pigmentosa and systemic mastocytosis. Br J Dermatol 1988;119:573-578.
49. Mican JM, de Biscglie AM, Fong TL, Travis WD, Kleiner DE, Baker B, Metcalfe DD: Hepatic involvement in mastocytosis: Clinicopathological correlations in 41 cases. Hepatology 1995;22:1163-1177.
50. Horny HP, Kaiseling E, Campbell M, Parwaresh MR, Lennert K: Liver findings in generalized mastocytosis: A clinicopathological study. Cancer 1989;63:532-538.
51. Grundfest S, Cooperman AM, Ferguson R, Benjamin S: Portal hypertension associated with systemic mastocytosis and splenomegaly. Gastroenterology 1980;78:370-373.
52. Kyriakou D, Kouroumalis E, Konsolas J, Ockonomaki H, Tzardi M, Kanavaros P, Manoussos O, Eliopoulos GD: Systemic mastocytosis: A rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis: Report of four cases. Am J Gastroenterol 1998;93:106-108.
53. Parker RI: Hematological aspects of mastocytosis. I. Bone marrow pathology in adult and pediatric systemic mast cell disease. J Invest Dermatol 1991;96:47S-51S.
54. Parker RI: Hematological aspects of mastocytosis. II. Management of hematologic disorders in association with systemic mast cell disease. J Invest Dermatol 1991;96:52S-54S.
55. Metcalfe DD: The liver, spleen, and lymph nodes in mastocytosis. J Invest Dermatol 1991; 96:45S-48S.
56. Metcalfe DD: Conclusions. J Invest Dermatol 1991;96:64S-65S.
57. Roberts LJ: Carcinoid syndrome and disorders of systemic mast cell activation including systemic mastocytosis. Endocrinol Metab Clin North Am 1988;17:415-436.
58. Bain BJ: Systemic mastocytosis and other mast cell neoplasms. Br J Haematol 1999;106:9-17.
59. Roberts J II, Oates JA: Biochemical diagnosis of systemic mast cell disorders. J Invest Dermatol 1991;96:19S-25S.
60. Brown MJ, Ind PW, Causon R, Lee TH: A novel double isotope technique for the enzymatic assay of plasma histamine: Application to estimation of mast cell activation assayed by antigen challenge in asthmatics. J Allergy Clin Immunol 1982;69:20-24.
61. Taylor SL: Histamine food poisoning: Toxicology and clinical aspects. CRC Crit Rev Toxicol 1986;17:91-128.
62. Keyzer JJ, de Mouchy JGR, van Doormal JJ, van Voorst Vader PC: Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites. NEJM 1983;309:1603-1605.
63. Westin J, Granerus G, Weinfield A, Wetterquist H: Histamine metabolism in polycythemia vera. Scand J Hematol 1975;15:45-57.
64. Granerus G, Olafsson JH, Roupe G: Studies on histamine metabolism in mastocytosis. J Inv Dermatol 1983;80:410-416.
65. Roberts LJ II: Quantification of the PGD2 urinary metabolite 9α-oh-11,15-dioxo-2,3,18,19-tetranorprost-5-ene-1,20-dioic acid by stable isotope dilution mass spectrometric assay. Methods Enzymol 1982;86:559-570.
66. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D: Time course of appearance and disappearance of human mast cell mediators in the circulation after anaphylaxis. J Clin Invest 1989; 83:155-159.
67. Campbell EW, Hector D, Gossain V: Heparin activity in systemic mastocytosis. Ann Intern Med 1979;90:940-941.
68. Penner J: Experience with a thrombin clotting time assay for measuring heparin activity. Am J Clin Pathol 1974;61:645-653.
69. Ridell B, Olafsson JH, Roupe G, Swolin B, Granereus G, Rodjer S, Enerback L: The bone marrow in urticaria pigmentosa and systemic mastocytosis. Arch Dermatol 1986;122:422-427.
70. Poppel MH, Gruber WF, Silber R, Holder AK, Christman RO: The radiological manifestations of urticaria pigmentosa (systemic mastocytosis). Am J Roentgenol 1959;82:239-248.
71. Sostre S, Handler HL: Bony lesions in systemic mastocytosis. Scintigraphic evaluation. Arch Dermatol 1977;113:1245-1247.
72. Johnson AC, Johnson S, Lester PD, Halter S, James E Jr: Systemic mastocytosis and mastocytosis like syndrome: Radiological features of gastrointestinal manifestations. South Med J 1988;81:729-733.
73. Scolapio JS, Wolfe J III, Malavet P, Woodward TA: Endoscopic findings in systemic mastocytosis. Gastrointest Endosc 1996;44:608-610.
74. Hirschowitz BL, Goarke JF: Effect of cimetidine on gastric hypersecretion and diarrhea in systemic mastocytosis. Ann Intern Med 1979; 90:769-771.
75. Soter NA, Austen Wasserman SI: Oral disodium cromoglycate on the treatment of systemic mastocytosis. NEJM 1979;301:465-469.
76. Lerno G, Glaats G, Coenen E, Herregods L, Rolly G: Anesthetic management of systemic mastocytosis. Br J Anaesth 1990;65:254-257.
77. Kluin-Nelemans HC, Jansen JH, Breukelman H: Response to interferon alfa-2b in a patient with systemic mastocytosis. NEJM 1992;326: 619-623.
78. Gasior-Chrzan B, Falk SS: Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists. Dermatology 1992;184:149-152.
79. Toogood J: Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol 1988;81:1-5.
80. Metcalfe DD: The treatment of systemic mastocytosis: An overview. J Invest Dermatol 1991; 96(suppl):55S-59S.
81. Provoa P, Ducla-Soares J, Fernandes A, Palma-Carlos AG: A case of systemic mastocytosis; therapeutic efficacy of ketotifen. J Intern Med 1991;229:475-477.
82. Barton J, Lavker RM, Schecter NM: Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 1985;121:1516-1523.
83. Czarnetzki BM, Algermissen B, Jeep S: Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol 1994;30:500-501.
84. Freidman B, Darling G, Norton J, Hamby L, Metcalfe D: Splenectomy in the management of systemic mast cell disease. Surgery 1990;107: 94-100.
85. Travis TD, Li CY, Bergstralh EJ, Yam LT, Swee RG: Systemic mast cell disease: Analysis of 58 cases and literature review. Medicine 1988;67: 345-368.